Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

Healthcare Biotechnology
PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Preveceutical Medical Inc
Bullboard Posts
User Avatar Image
(251)
•••
Comment by CanadaCoinon Oct 03, 2019 6:39pm
66 Views
Post# 30194169

RE:RE:RE:RE:The Cannabis Bubble has burst!

RE:RE:RE:RE:The Cannabis Bubble has burst!
richy546 wrote:

The only reason why we're sitting at 3c is because the whole cannabis market crashed. Even Aurora was 75% down from its all time high.

 

If you really did you DD, you would have watched this video.
https://ca.proactiveinvestors.com/companies/news/214562/preveceutical-medical-appoints-dr-makarand-jawadekar-as-president-214562.html

 

Clearly , the president of company, said that they will start signing deals after they get the patent of the Sol gel delivery platform. 



Seriously.....then ask yourself why PREV made a public announcement seeking a signed deal a year ago....if it's all about patents??

And why didn't Asterion not move forward with their 51% Sol-Gel Acquistion Option? You got all excited back in August over this deal....but they [Asterion] then left you hanging out to dry! 

I am amazed that you are ok with being treated like this. But it's your money. :) 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities